Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Portal St. Lucia.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on May 21, 2025
Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
GlobeNewswire
·
May 21, 2025
Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline Paris, May 22, 2025. Sanofi announced today that it has entered into an agreement to acquire Vigil Neuroscience, Inc. …
Communiqué de presse : Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologie
GlobeNewswire
·
May 21, 2025
Sanofi va acquérir Vigil Neuroscience, Inc. et ajouter un nouveau médicament expérimental pour le traitement de la maladie d’Alzheimer à son portefeuille en neurologie Paris, le 22 mai 2025. Sanofi annonce aujourd’hui avoir conclu un accord en vue de l’ …
Seize the rising cycle of Bitcoin and earn $8,888 in passive income every day
GlobeNewswire
·
May 21, 2025
Washington, D.C., USA, May 21, 2025 (GLOBE NEWSWIRE) -- PAIRMiner, an advanced platform offering mining power services. Recently, Bitcoin has made a strong comeback, with its price soaring and reigniting global investors' passion and confidence in …
BlackRock® Canada Announces Final May Cash Distributions for the iShares® Premium Money Market ETF
GlobeNewswire
·
May 21, 2025
TORONTO, May 21, 2025 (GLOBE NEWSWIRE) -- BlackRock Asset Management Canada Limited (“BlackRock Canada”), an indirect, wholly-owned subsidiary of BlackRock, Inc. (NYSE: BLK), today announced the final May 2025 cash distributions for iShares Premium Money …
CORRECTION -- LiveRamp Announces Fourth Quarter and Fiscal Year 2025 Results
GlobeNewswire
·
May 21, 2025
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- In a release issued earlier today under the same headline by LiveRamp (NYSE: RAMP), please note the GAAP operating income and Non-GAAP operating income for the first quarter of fiscal 2026 and fiscal 2026 …
Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters’ Option to Purchase Additional Shares, and Closing of Private Placement
GlobeNewswire
·
May 21, 2025
Public offering results in gross proceeds of $57.5 million Private placement results in gross proceeds of approximately $20.3 million GERMANTOWN, Md., May 21, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology …
Vaxart Announces Adjournment of Annual Meeting of Stockholders
GlobeNewswire
·
May 21, 2025
Meeting adjourned to June 2, 2025 at 8:30 a.m. Pacific Time Vaxart encourages all stockholders of record on March 26, 2025 who have not yet voted to do so by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) …
iRhythm Technologies to Participate in Upcoming Investor Conferences
GlobeNewswire
·
May 21, 2025
SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is …
Cellectis’ Annual Shareholders General Meeting to be Held on June 26, 2025
GlobeNewswire
·
May 21, 2025
NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today …
Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs
GlobeNewswire
·
May 21, 2025
PITTSBURGH, May 21, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq: XAGE) (“XAGE,” the “Company,” “we,” “us,” or “our”), a company focused on extending human longevity and healthy aging through innovative products in regenerative bio- …
Nanobiotix Provides First Quarter 2025 Operational and Financial Update
GlobeNewswire
·
May 21, 2025
Dosing of a first patient in the CONVERGE study, a Phase 2 randomized controlled clinical trial for patients with stage 3 unresectable non-small cell lung cancer Presentation of data at the European Lung Cancer Conference in a Phase 1 study of re- …
Nanobiotix fait le point sur sa trésorerie et son activité opérationnelle du premier trimestre 2025
GlobeNewswire
·
May 21, 2025
Traitement du premier patient dans l’étude CONVERGE, un essai clinique contrôlé randomisé de Phase 2 chez des patients atteints d’un cancer du poumon non à petites cellules (CPNPC) non résécable de stade 3. Présentation de données à l’ELCC (European Lung …
Zoom Communications Reports Financial Results for the First Quarter of Fiscal Year 2026
GlobeNewswire
·
May 21, 2025
First quarter total revenue of $1,174.7 million, up 2.9% year over year as reported and 3.4% in constant currency First quarter Enterprise revenue of $704.7 million, up 5.9% year over year First quarter GAAP operating margin of 20.6% and non-GAAP operating …
nCino to Participate in Upcoming Investor Events
GlobeNewswire
·
May 21, 2025
WILMINGTON, N.C., May 21, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced its participation in the following investor conferences: Baird’s 2025 Global Consumer, …
Synaptics Names Rahul Patel as President and Chief Executive Officer
GlobeNewswire
·
May 21, 2025
SAN JOSE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) announced today that Rahul Patel has been appointed President and Chief Executive Officer, and a Director of the company. Patel succeeds Synaptics CFO Ken Rizvi, who …
LiveRamp Announces Fourth Quarter and Fiscal Year 2025 Results
GlobeNewswire
·
May 21, 2025
Q4 Revenue up 10% year-over-year FY25 Operating Cash Flow increases 46% year-over-year FY25 Share Repurchases totaled $101 million SAN FRANCISCO, May 21, 2025 (GLOBE NEWSWIRE) -- LiveRamp® (NYSE: RAMP), a leading data collaboration platform, today …
Raj Judge Joins Zscaler’s Board of Directors and as EVP of Corporate Strategy & Ventures
GlobeNewswire
·
May 21, 2025
SAN JOSE, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, is pleased to announce that Raj Judge has been appointed to the company’s Board of Directors and joined as Executive Vice President of Corporate …
Pliant Therapeutics Presents Clinical and Preclinical Data at the American Thoracic Society International Conference
GlobeNewswire
·
May 21, 2025
SOUTH SAN FRANCISCO, Calif., May 21, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company led oral and poster presentations of clinical and preclinical data this week as part of the American Thoracic Society ( …
Immix Biopharma to Host KOL Event to Discuss NXC-201 Clinical Data Presented at ASCO 2025 in relapsed/refractory AL Amyloidosis
GlobeNewswire
·
May 21, 2025
– Virtual KOL Event Tuesday, June 3, 2025 3:00pm ET – – Attend the event here: https://lifescievents.com/event/immix-asco – LOS ANGELES, CA, May 21, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), clinical- …
AI와 알고리즘 구동 플랫폼 TrialWire, Fierce CRO Award “우수 환자 모집 및 유지” 부문 최종 후보로 선정
GlobeNewswire
·
May 21, 2025
샌프란시스코, May 22, 2025 (GLOBE NEWSWIRE) -- TrialWire가 Fierce Biotech의 Fierce CRO Award 우수 환자 모집 및 유지 부문에서 최종 후보로 선정되었다. TrialWire는 AI와 알고리즘으로 구동되는 환자 모집 및 등록 플랫폼으로, Salesforce Health Cloud를 기반으로 설계되어 최상급의 데이터 및 IP 보안을 보장한다. 이 플랫폼은 등록 환자당 요금을 지불하는 위험 분담형 …